Vinorelbine tartrate

Vinorelbine tartrate is mainly used to treat non-small cell lung cancer, either alone or combined with cisplatin, metastatic breast cancer,other cancers under investigation or off-label use, including aggressive fibromatosis, Hodgkin lymphoma, ovarian cancer, and metastatic cervical cancer. It is grouped under the following drug class(es): Antineoplastic agents, Cytotoxics, Microtubule inhibitors and Vinca alkaloids. Its therapeutic use is listed as antineoplastics. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Vinorelbine ditartrate and Vinorelbine liposomal. Its PubChem CID is 11607738.

CAS No 125317-39-7
Molecular Formula C53H66N4O20
Molecular Weight 1079.1 g/mol
Synonyms bis((2R,3R)-2,3-dihydroxybutanedioic acid);methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(12S,14R)-16-ethyl-12-methoxycarbonyl-1,10-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8,15-pentaen-12-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate

Frequently Asked Questions